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SUMMARY
NR3A is the only NMDA receptor (NMDAR) subunit that down-regulates sharply prior to the
onset of sensitive periods for plasticity, yet the functional importance of this transient expression
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remains largely unknown. To investigate the possibility that removal/replacement of juvenile
NR3A-containing NMDARs is involved in experience-driven synapse maturation, we used a
reversible transgenic system that allowed persistent NR3A expression in the postnatal forebrain.
We found that removal of NR3A is required to develop strong NMDAR currents, full expression
of long-term synaptic plasticity, a mature synaptic organization characterized by more synapses
and larger postsynaptic densities, and the ability to form long-term memories. Deficits associated
with prolonged NR3A were reversible, as late-onset suppression of transgene expression rescued
both the synaptic and memory impairments. Our results suggest that NR3A behaves as a
molecular brake to prevent the premature strengthening and stabilization of excitatory synapses,
and that NR3A removal might thereby initiate critical stages of synapse maturation during early
postnatal neural development.
INTRODUCTION
The development of functional neural circuits relies on the activity-dependent rearrangement
of synaptic connectivity, likely via long-term plasticity mechanisms that stabilize some
synapses while weakening or eliminating others. Most rearrangement activity occurs during
sensitive periods of postnatal development, and typically diminishes as adult patterns of
connectivity are established. The sequence of molecular events underlying the beginning
and end of these sensitive periods is not well understood, but the replacement of “juvenile”
with “mature” NMDAR subtypes (Carmignoto and Vicini, 1992; Crair and Malenka, 1995;
Sheng et al., 1994) is thought to contribute by tuning the plasticity potential of individual
synapses. This tuning helps determine which inputs will be strengthened and directs the
overall balance between synapse elimination and stabilization (Perez-Otaño and Ehlers,
2004). Accumulating evidence suggests that failure to achieve the appropriate balance
results in a number of CNS disorders ranging from schizophrenia to autism and mental
retardation (Bagni and Greenough, 2005; Chao et al., 2007; Durand et al., 2007; Frankle et
al., 2003). Thus, understanding the mechanisms linking NMDAR exchange to brain
maturation is central for understanding not only neurodevelopment and information storage,
but also how aberrations in NMDAR transmission lead to neural network dysfunctions.
NMDARs are heteromers containing NR1 subunits and combinations of four NR2 (A–D)
and two NR3 (A–B) subunits. Most research to date has focused on the role of the
developmental switch between predominantly NR2B- to NR2A-containing NMDARs
because it occurs in many brain regions and can be driven by neural activity and experience
(Barria and Malinow, 2002; Bellone and Nicoll, 2007; Philpot et al., 2001). In contrast, little
is known about the importance of the removal/replacement of NR3A-containing NMDARs
despite growing evidence that non-conventional NR3A subunits are well positioned to be
potent regulators of NMDAR function. First, inclusion of NR3A results in the formation of
heteromeric receptors (NR1/NR2/NR3A) with reduced Ca2+ permeability and low
sensitivity to Mg2+ blockade (Perez-Otaño et al., 2001; Sasaki et al., 2002), thus modifying
two major properties of classical NMDARs (NR1/NR2 heteromers). Second, NR3A is
prominently expressed during a narrow temporal window of postnatal development that
correlates with periods of intense synaptogenesis and pruning and later becomes down-
regulated, just prior to the onset of critical period plasticity (Perez-Otaño et al., 2006; Wong
et al., 2002). Third, genetic deletion of NR3A increases spine density, indicating that NR3A
might participate in synapse formation or elimination (Das et al., 1998). Finally, removal of
NR3A-containing NMDARs can be regulated by activity via selective recruitment of the
endocytic adaptor PACSIN/syndapin 1 (Perez-Otaño et al., 2006), suggesting that regulated
removal might occur at the level of individual synapses rather than non-selectively along
entire dendritic branches or trees. Yet, if and how NR3A subunits modulate synaptic
plasticity, synapse maturation, or learning is unknown, leaving an important gap in our
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understanding of NMDAR-mediated development. Assessing the role of NR3A may also be
important for understanding human disease. For example, genetic variations in NR3A alter
human brain function (Gallinat et al., 2007), and abnormal NR3A expression is associated
with schizophrenia and bipolar disorder (Mueller and Meador-Woodruff, 2004).
To address the role of NR3A subunits in synapse development and plasticity, we generated
transgenic mice in which NR3A expression could be prolonged beyond its natural time
window in postnatal forebrain neurons. We found that prolonging NR3A expression results
in synaptic NMDAR hypofunction, deficits in long-term potentiation (LTP), reduced
postsynaptic maturation at Schaffer collateral-CA1 synapses of the hippocampus, and
impairs behavioral flexibility and memory consolidation. Conversely, genetic deletion of
NR3A yielded a premature concentration of NMDARs at postsynaptic sites, enhancing
synaptic NMDAR currents and promoting an earlier developmental onset of LTP. Both the
synaptic and cognitive deficits resulting from persistent NR3A expression could be reversed
by suppressing transgene expression at later stages. These findings indicate that the presence
of NR3A maintains synapses in an anatomically and functionally juvenile state that is
refractory to the induction of LTP and structural plasticity, and incapable of supporting
long-term memory storage.
RESULTS
Generation of GFPNR3A transgenic mice
We used the tetracycline-controlled transactivator (tTA) system to generate transgenic mice
that express the NR3A coding region tagged with enhanced green fluorescent protein
(GFPNR3A) under the control of the tetO promoter (for details and functionality of the
tagged construct see Perez-Otaño et al., 2001, 2006). To achieve postnatal expression of the
transgene, these animals were crossed to mice expressing tTA under the CaMKIIα promoter
(Mayford et al., 1996) (Figure 1A). Resulting double transgenic mice were born with the
expected Mendelian frequencies, were fertile and of normal weight, and grew to adulthood
with no overt behavioral abnormalities. Direct or immunohistochemically-enhanced GFP
visualization showed that GFPNR3A was expressed in forebrain areas including the
hippocampus (mainly CA1 pyramidal neurons), regions of the neocortex, amygdala,
striatum, and olfactory tubercle (Figures 1B and S1). At the subcellular level, GFPNR3A
was localized in cell bodies and dendritic fields of CA1 and neocortical pyramidal neurons
(Figure 1C). The regional pattern of GFPNR3A expression overlapped with neuronal
populations where NR3A is endogenously expressed earlier in development (see
comparative mapping analysis in Table S1). Temporally, GFPNR3A expression began
around postnatal day 12 (P12) and steadily increased into adulthood, reaching plateau levels
by P25, thus coinciding with and counteracting the developmental decline of endogenous
NR3A expression in rodent forebrain (Figures S1 and S2, see Perez-Otaño et al., 2006;
Wong et al., 2002). Administration of doxycycline for 5 days completely switched off
transgene expression in both young (Figure 1D) and adult mice (data not shown).
Prolonged GFPNR3A expression did not affect gross brain cytoarchitecture or development.
Histochemical examination did not reveal structural abnormalities in forebrain regions with
high transgene expression such as the cortex, hippocampus, or striatum (Figure S1). No
overt differences were found in dendritic morphologies of CA1 hippocampal neurons as
shown by normal intensity and expression pattern of the dendritic marker MAP2 (Figure
S1), or by Golgi impregnation (data not shown). We additionally stained for cytochrome
oxidase to examine the patterned barrel structure of the primary somatosensory cortex, as
the formation of these patterns has been reported to depend on NMDAR function (Iwasato et
al., 2000), but no differences were detected (Figure S1).
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Incorporation of GFPNR3A-containing NMDARs into synapses
Because the developmental down-regulation of NR3A coincides with major maturational
changes at excitatory synapses, including changes in the kinetic properties and postsynaptic
attachment of NMDARs, synaptic plasticity, and spine formation and growth, we examined
the effects of prolonged NR3A expression in the CA1 region of the hippocampus at higher
resolution (Groc et al., 2006; Harris and Teyler, 1984; Muller et al., 1989; Harris et al.,
1992). Pyramidal neurons in CA1 express NR3A at peak levels between P6 – P15, but
expression is markedly down-regulated by P25 and remains lower into adulthood as in other
brain regions (Figure S2A, B).
A series of experiments demonstrated that GFPNR3A had incorporated into synaptic
NMDARs by P25. First, immunohistochemical analysis showed that GFPNR3A expression
was up-regulated in CA1 between P12–P25, coinciding with the decline in endogenous
NR3A (Figure S2C). Western blots using an anti-NR3A antibody revealed a GFPNR3A
band of the expected size in hippocampal membrane extracts of transgenic mice (~160 kDa,
Figure S3A), which was absent in controls. GFPNR3A was enriched in synaptic fractions to
a similar magnitude as endogenous NR3A (Figure S3A, Das et al., 1998; Perez-Otaño et al.,
2006). Second, co-immunoprecipitation experiments showed that GFPNR3A interacts with
NR1, NR2A and NR2B subunits, matching the behavior of native NR3A subunits and
indicating that GFPNR3A assembles into heterotrimeric NMDAR complexes (Figure 2A,
see Al Hallaq et al., 2002). The AMPAR subunit GluR2 was not detected in
immunoprecipitates, demonstrating the specificity of subunit assembly. There were no
discernible changes in the levels of NR1, NR2A or NR2B in total membranes of GFPNR3A
transgenics relative to controls, or in light membrane fractions that contain intracellular
organelles including endoplasmic reticulum and Golgi membranes (Figure S3C, D).
Combined with the observation that synaptic enrichment of GFPNR3A was comparable to
that of endogenous NR3A, these results indicate that intracellular trafficking of GFPNR3A
subunits was essentially normal and that GFPNR3A expression did not cause non-specific
intracellular sequestration of endogenous NMDAR subunits. Intriguingly, a selective
decrease in the abundance of NR2B subunits was observed in synaptic fractions (Figure
S3E).
Third, at the subcellular level, dendritic GFPNR3A clusters colocalized with the
postsynaptic marker Shank in the CA1 stratum radiatum (Figure S3B), confirming that
GFPNR3A subunits were at synapses. GFPNR3A was also seen in peri- and extrasynaptic
sites, as is the case for endogenous NR3A (Perez-Otaño et al., 2006).
Fourth, to assess if incorporation of GFPNR3A altered synaptic NMDAR function, we
measured several features of NMDAR-mediated excitatory postsynaptic currents (EPSCs) in
CA1 pyramidal neurons of brain slices from P21–25 transgenic and control mice; whole-cell
patch-clamp recordings in transgenic mice were visually guided by GFP expression. As
expected if a higher fraction of synaptic NMDARs contained the NR3A subunit (Sasaki et
al., 2002; Tong et al., 2008), we found that GFPNR3A expression significantly reduced the
overall amplitude of NMDAR EPSCs evoked by stimulating Schaffer collaterals and
decreased the rectification in the current-voltage (I–V) relationship that is produced by Mg2+
blockade (Figure 2B, C). Together, these results indicate that transgenic GFPNR3A subunits
assemble with native NR1 and NR2 subunits to form non-conventional, synaptically-
activated NMDAR channels and corroborate previous findings that NR3A subunits
incorporate into synapses (Perez-Otaño et al., 2006; Tong et al., 2008). Although longer
single-channel open times have been observed for recombinant NR3A-containing NMDARs
(Sasaki et al., 2002; Perez-Otaño et al., 2001), we did not detect differences in the duration
of macroscopic NMDAR currents (Figure S4A). This observation is consistent with the lack
of differences in the duration of macroscopic NMDAR currents in NR3A knockout mice
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(Sasaki et al., 2002), and with previous studies showing that decay kinetics are dominated by
other factors such as glutamate unbinding rates (Pan et al., 1993).
GFPNR3A expression levels detected by biochemical techniques were low, and a precise
quantification of the amount in CA1 pyramidal neurons relative to endogenous levels during
development was precluded by contributions of a population of CA1 stratum oriens
interneurons which retain high endogenous NR3A expression into adulthood (Figure S3A).
To confirm functionally that sufficient levels of transgenic GFPNR3A subunits were being
expressed to maintain synaptic NMDARs in their juvenile state, we took advantage of the
decreased sensitivity to Mg2+ blockade of NR3A-containing receptors (Figure 2C, D). A
single-parameter index of sensitivity to Mg2+ blockade (1/C0) was extracted from current-
voltage relationships of NMDAR currents using a theory derived previously to describe
current flux through NMDARs in the presence of Mg2+ (Jahr and Stevens, 1990; Appendix
S1). The analysis showed that the sensitivity to Mg2+ block at synapses of P21–P25
GFPNR3A-expressing neurons was similar to the sensitivity at P6–P8 wild-type synapses
(when endogenous NR3A expression is highest), and significantly less than at P21–P25
control synapses (when NR3A expression is low) or at P6–P8 NR3A knockout synapses
(Figure 2E). These results provide functional evidence that transgenic GFPNR3A expression
prolonged peak juvenile synaptic NR3A levels in the face of endogenous down-regulation,
and that functional levels of synaptic NR3A in GFPNR3A transgenic mice were similar to
levels expressed during early development in wild-type mice.
Altered long-term synaptic plasticity
We next examined whether prolonging NR3A expression altered long-term synaptic
plasticity. In a blind fashion, we compared the magnitude of LTP measured in CA1 field
potential recordings after high-frequency Schaffer collateral stimulation (HFS, three trains at
100 Hz, 1 sec). LTP was significantly reduced in slices from GFPNR3A transgenics when
compared to control littermates (control, 167 ± 8%; GFPNR3A, 127 ± 8%, p = 0.0047,
Figure 3A). To test whether the deficit could be overcome with a stronger LTP induction
protocol, we measured the responses to three repeated applications of high-frequency
stimulation trains, each separated by a 5-min interval. However, the LTP deficit was still
observed (control, 208 ± 17 %; GFPNR3A, 157 ± 15%, p = 0.033, Figure 3B). Long-term
depression (LTD) induced by low-frequency stimulation was unaffected (Figure 3C).
Paired-pulse facilitation (PPF) ratios were also unchanged (Figure 3D), suggesting that
release probability and presynaptic function are normal in GFPNR3A transgenics. These
findings demonstrate that prolonging NR3A expression alters the ability of synapses to
undergo potentiation, and that the effect is likely due to postsynaptic alterations. To
determine if synaptic alterations were reversible, doxycycline was given to GFPNR3A
transgenics starting at P26 (14 days, from P26–P40, scheme in Figure 3E). This
administration protocol allowed GFPNR3A expression from its onset at P12 until P26, when
defects in LTP are manifest, but suppressed GFPNR3A expression afterwards. Switching off
transgene expression restored normal levels of LTP, which were indistinguishable from
controls (Figure 3E).
Changes in the structure and function of excitatory synapses
The balance between LTP and LTD, or related NMDAR-dependent mechanisms, is thought
to control the remodeling of neuronal circuitry during postnatal development by regulating
synapse maturation and/or elimination. Thus, we examined if prolonged NR3A expression
affected the number, structure, or composition of CA1 excitatory synapses.
Individual control and GFPNR3A-expressing CA1 pyramidal neurons were filled with the
red fluorophore Alexa 568 in acute slices from P25 mice via the whole-cell patch-clamp
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recording pipette, and high-resolution confocal reconstructions of the filled neurons were
obtained. Only a fraction of CA1 neurons expressed GFPNR3A, allowing the selection of
control neurons from transgenic slices (Figure 4A, B). We found that spine density was
significantly reduced in apical dendrites of GFPNR3A-expressing neurons (spines per 10
μm dendrite: control, 10.8 ± 0.9; GFPNR3A, 7.7 ± 0.6, p = 0.04, 29% decrease, Figure 4 C,
D); effects were nominally more pronounced among the population of stable mushroom-
type spines (control, 5.2 ± 0.6; GFPNR3A, 3.3 ± 0.2, p = 0.06, 36% decrease, Figure 4E).
Reductions in spine number were confirmed in Golgi-stained CA1 pyramidal neurons from
control and transgenic mice, where experiments and analysis were conducted blind to
genotype. By P25, the average spine density was significantly lower in apical dendrites of
CA1 neurons from GFPNR3A transgenic mice relative to controls (spines per 10 μm
dendrite: control, 9.3 ± 0.3; GFPNR3A, 7.9 ± 0.3, p = 0.002, 15% decrease, Figure 4F, G).
As expected, the magnitude of the defect was less than that detected in fluorescence fill
experiments, because the Golgi silver impregnation does not allow distinction between
GFPNR3A-expressing and non-expressing neurons.
At higher resolution, electron microscopy revealed a significant decrease in the number of
asymmetric synapses in the CA1 stratum radiatum of P25 GFPNR3A transgenics, which
was of similar magnitude to the changes in spine density detected by Golgi (synapses per
field: control, 11.5 ± 0.1; GFPNR3A transgenic, 9.7 ± 0.1, p = 0.00001, 17% decrease,
Figure 5A, B). In addition, synapses were smaller in transgenic mice, as shown by a shift in
the overall synapse distribution toward synapses with shorter postsynaptic densities (PSDs)
and a significantly reduced mean PSD length (Figure 5C). By P35, the number of synapses
in transgenic mice was comparable to controls but the decrease in PSD length was
maintained (Figure 5D, E). Taken together with the preferential decrease noted in the
proportion of mature mushroom-type spines, these data indicate an inhibitory effect of
NR3A on synapse/spine growth. To determine if decreases in PSD length were reversible,
we treated mice with doxycycline (10 days, from P26–P35, scheme in Figure 5).
Doxycycline administration completely reversed the effect of GFPNR3A on PSD length
(Figure 5E), indicating that alterations in synapse size resulted from acutely altered levels of
NR3A protein and did not reflect a permanent developmental deficit caused by increased
NR3A expression during an earlier time window.
Synapse size has been shown to correlate with AMPAR number and synaptic strength in
some studies (Nusser et al., 1998; Takumi et al., 1999). Although we observed reductions in
the size of evoked AMPAR-mediated EPSCs (Figure S4B) and in the frequency of
spontaneous AMPAR miniature EPSCs (control, 0.50 ± 0.06 Hz; GFPNR3A, 0.34 ± 0.02
Hz, p < 0.02, 32% decrease, Figure 6A, B), we did not detect changes in quantal amplitude
(control, 13.83 ± 0.70 pA; GFPNR3A, 13.43 ± 0.45 pA, Figure 6A, C). Further, the relative
contribution of AMPAR-mediated EPSCs at synapses that are maintained in GFPNR3A
transgenic mice was unchanged, as shown by lack of detectable changes in NMDAR/
AMPAR ratios estimated from spontaneously occurring miniature EPSCs or synaptically
evoked responses (Figure 6D). Together with the anatomical measurements, these results are
consistent with NR3A expression altering the number of functional synapses without
affecting the AMPAR content of remaining synapses.
The above results support the hypothesis that the presence of juvenile NMDARs containing
NR3A subunits limits functional and structural plasticity, preventing naïve synapses from
undergoing maturation and stabilization. When NR3A levels are elevated during
developmental stages of robust pruning, this leads to increased loss of immature, relatively
inactive spines (Figure S5A, left). Conversely, removal of NR3A at active synapses would
be expected to allow enhanced plasticity and thereby enable synapse maturation and
stabilization as well as synapse and spine growth (Figure S5A, right). If this is true, one
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could predict that NR3A should be normally absent from large synapses. To test this, we
analyzed the synaptic distribution of endogenous NR3A in wild-type mice using
immunogold electron microscopy. NR3A was indeed preferentially localized to small
synapses (Figure S5B). Remarkably, there was a sharp decrease in the number of NR3A
immunogold particles with increasing synapse size, while NR1 particle numbers were
roughly constant across synapse sizes as shown in previous studies (Figure S5C, Petralia et
al., 1999; Takumi et al., 1999).
If NR3A acts as a “molecular brake” to prevent premature synapse strengthening, a second
prediction would be that earlier postnatal down-regulation of NR3A should result in stronger
LTP and accelerated maturation of synapses. In wild-type mice, LTP becomes easier to
induce and of larger magnitude in hippocampal CA1 between P6–P8 and P15, coinciding
with the onset of NR3A down-regulation and removal mechanisms (Harris and Teyler,
1984; Muller et al., 1989, Figure S2). Experiments in NR3A knockout mice showed that
LTP was easier to induce in young (P6–P8) mice when NR3A was absent (Figure 7A),
while LTD was unchanged (Figure S6). Further, a quantitative biochemical analysis showed
that the postsynaptic abundance of NR1 subunits was higher in P6–P8 NR3A knockout
mice. Total NR1 expression was unchanged, suggesting that synaptic concentration and
stabilization of NMDARs, one of the initial events driving synapse maturation, also occurs
earlier in the absence of NR3A (Figure 7B). This correlated with an earlier enhancement of
synaptic NMDAR currents in NR3A knockout mice that is in agreement with previous
results (Figure 7C, Sasaki et al., 2002).
GFPNR3A transgenic mice learn but display altered long-term memory storage
To determine whether changes in synaptic plasticity and structure resulting from prolonged
NR3A expression led to behavioral impairments, we tested adult GFPNR3A transgenics on
learning tasks known to require NMDAR activation. Spatial memory was evaluated using
the Morris water maze, in which mice are trained to find a hidden platform by using visual
cues (“acquisition”). Both control and GFPNR3A transgenics learned to swim to the hidden
platform (Figure 8A–C). GFPNR3A transgenics were initially more successful than
controls, but by day 4 swim distances and times were similar (Figure 8B, C). During probe
trials in which the platform was removed from the pool, both control and transgenic mice
spent more time in the target quadrant searching for the platform (days 3 and 6 of training,
Figure 8E), confirming that they had learned the platform location. However, probe trials
conducted 21 days after training showed that long-term memory storage was significantly
weaker in GFPNR3A transgenics (day 27, p < 0.03 vs control, Figures 8E and S7).
To test their flexibility in handling spatial information, GFPNR3A transgenics were trained
to learn a new platform location (“reversal”) after a 3-day retraining interval. Reversal
learning was significantly slower than in controls (Figure 8B, C, F). Further, probe trials
conducted another 21 days later revealed that long-term memory of the new platform
location was extinguished in the transgenics (day 57, p < 0.005 vs control, Figures 8F and
S7). No differences were observed in the visible platform version of the task (Figure 8D) or
in swim velocities and distances (Table S2), indicating normal sensory-motor function and
coordination.
To evaluate the ability of GFPNR3A transgenics to form and store associative memories, we
examined two types of non-spatial hippocampal-dependent tasks: social transmission of
food preference and object recognition. Performance was measured at 20 min and after
delays of 24 hrs and 10 days to assess both short-term and long-term memory. The social
transmission of food preference task is based on the ability of rodents to develop a
preference for foods that they smell on the breath of another individual. The task consisted
of three stages: 1) a demonstrator mouse consumed a flavored diet; 2) tester mice were given
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20 min to interact with the demonstrator; and 3) tester mice were given a choice to consume
the familiar or a novel flavored diet. Although both genotypes preferred the familiar diet at
20 min and 24 hrs, GFPNR3A transgenics showed weaker preferences than controls (Figure
9A). By 10 days, the transgenics failed to display any preference whereas controls
maintained a strong preference for the familiar diet (Figure 9A). There was a significant test
day by genotype interaction (F(2,36) = 9.617, p < 0.001), reflecting poorer memory of
GFPNR3A transgenics with longer retention delays. Differences could not be attributed to
changes in feeding behavior because no genotype differences in latency to eat, bowl contacts
and total amounts eaten were observed at 20 min or 24 hrs (Figure S8).
In the object recognition memory test, control mice displayed a strong preference for the
novel object at all time points (Figure 9B). GFPNR3A transgenics also showed clear
preference for the novel object at 20 min, but their ability to retain this preference had
weakened at 24 hrs and was lost by 10 days (genotype by test day interaction, F(2,36) =
11.543, p < 0.001, Figure 9B). No genotype differences were noted for total object
exploration time (20 min: control, 37.1 ± 3.5%, GFPNR3A, 39.4 ± 2.5%; 24 hrs: control,
42.6 ± 3.3%, GFPNR3A, 40.4 ± 2.5%; 10 days: control, 50.3 ± 2.5%, GFPNR3A, 48.9 ±
3.6%). Collectively, the behavioral data show that short-term memory processes appear
intact in GFPNR3A transgenic mice, but their behavioral flexibility and ability to
consolidate/retain the memories formed is severely impaired.
Defects in long-term memory are reversible
To evaluate if defects in long-term memory could be rescued, adult control and transgenic
mice were treated with doxycycline (14 days) after allowing GFPNR3A expression at earlier
stages, and examined in the novel object recognition task at 20 min, 24 hrs and 10 days.
Both controls and doxycycline-treated GFPNR3A transgenic mice showed clear and
statistically indistinguishable preferences for the novel object at all test times (Figure 9C).
Comparison of the preference scores revealed that doxycycline-treated GFPNR3A
transgenic mice had marked increases in preference for the novel object at both 24 hrs (p <
0.001) and 10 days (p < 0.001) relative to untreated transgenic mice. No differences were
found between doxycycline-treated and untreated control animals. Similar conclusions based
upon the reversibility seen for defects in LTP and synapse structure strongly indicate that
memory deficits caused by prolonged expression of NR3A did not reflect permanent
changes in neural circuitry. Moreover, they demonstrate that suppressing transgenic
GFPNR3A expression is sufficient for the re-establishment of a functional neural network
and recovery of learning and memory.
DISCUSSION
The aim of this study was to understand the functional importance of NR3A down-
regulation in development by generating transgenic mice in which NR3A was persistently
expressed in postnatal forebrain neurons. We found that prolonging NR3A expression
prevents glutamatergic synapse maturation by limiting synapse potentiation and growth, and
decreasing spine density, whereas knocking out endogenous NR3A conversely accelerates
synaptic maturation events. Maturation deficits caused by altered NR3A expression were
accompanied by major impairments in learning and memory processes. Importantly,
however, both synaptic and cognitive deficits could be reversed at later stages,
demonstrating that appropriate maturation of synapses can still be achieved if normal NR3A
expression is restored. We propose that NR3A subunits place limits on the ability of
synapses to potentiate and mature, and, due to their unique temporal pattern of expression,
might act as a gatekeeper to ensure that the maturation of synapses is appropriately timed
during postnatal brain development. Moreover, our results suggest that activity-dependent
regulation of NR3A expression could serve as a switch to initiate selective synapse
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maturation by conferring the potential for localized, lasting changes in synaptic strength
(Figure S5). These roles of NR3A are essential for the refinement and consolidation of
neuronal networks.
NR3A: Regulator of synaptic maturation and pruning
Prolonged expression of NR3A subunits decreased the number and size of synaptic contacts,
with persistent decreases in PSD length suggesting a dominant role of NR3A in limiting
synaptic size. This notion is also supported by our observation that large synapses (PSD
length > 250 nm) normally lack NR3A. Although the mechanism by which NR3A limits
synapse size is currently unknown, one possibility is the reduced LTP at NR3A-expressing
synapses. Stimuli that induce LTP are known to trigger spine growth and persistent PSD
enlargement via activation of NMDARs (Engert and Bonhoeffer, 1999; Toni et al., 2001;
Matsuzaki et al., 2004; Park et al., 2006), and lower Ca2+ influx through NR3-containing
receptors likely decreases activity-dependent signaling and transcription, as well as
cytoskeletal remodeling (West et al., 2002; Ackermann and Matus, 2003), two of the
processes underlying the stabilizing effects of LTP on spine morphology. Consistent with
this possibility, early removal of endogenous NR3A results in both robust LTP and
enhanced stabilization and growth of excitatory synapses (this study and Das et al., 1998).
However, other genetic mutations of the NMDAR have been shown to modify LTP without
altering synapse structure, suggesting dissociation between NMDAR-dependent plasticity
and excitatory synapse maturation. For instance, CA1-specific NR1 knockout mice lack
hippocampal LTP but have normal spine densities (Rampon et al., 2000; Tsien et al., 1996),
and NR2B overexpression enhances LTP without changing spine density or size (Tang et al.,
1999). Additionally, forebrain-specific NR1 deletion was reported to increase spine density
in layer IV barrel neurons (Datwani et al., 2002, see also Adesnik et al., 2008), indicating
that NMDAR activity limits, rather than promotes, synapse maturation. One key difference
might be that selective prolonged expression or early removal of NR3A subunits alters the
ability to induce LTP without modifying LTD, whereas previous NMDAR manipulations
which eliminated NMDARs by targeting the NR1 locus also reduced or eliminated LTD,
likely removing a critical mechanism for driving synapse pruning.
Alternatively, or concomitant with inhibiting LTP, NR3A may have a direct role in the
destabilization and elimination of synapses because of its ability to mediate tonic, non-
coincident calcium entry, one of the signals thought to contribute to synaptic pruning (Day
et al., 2006), or through the recruitment via its intracellular domains (with limited homology
to NR1 and NR2 subunits) of signaling complexes or actin regulators driving synapse
disassembly. A number of intracellular binding partners of NR3A have already been
identified. They include the catalytic subunit of protein phosphatase 2A, the endocytic
adaptor and actin regulator PACSIN/syndapin 1, the scaffolding protein plectin, a cell cycle
and apoptosis regulatory protein (CARP-1), and a regulator of G-protein signaling (GPS2/
AMF1) (Chan and Sucher, 2001; Eriksson et al., 2007). Finally, the NR3A subunit can exert
potent effects on receptor trafficking. For instance, NR3A can target NMDARs for
endocytosis to facilitate synapse elimination (Perez-Otaño et al., 2006). In addition, NR3A-
containing NMDARs are less firmly attached to PSDs than classical NMDARs (Perez-Otaño
et al., 2006) and their diffusion properties may differ, keeping synapses in a labile, immature
state (Figure S5). Impaired stabilization of NMDARs at postsynaptic sites as a result of
persistent NR3A expression could contribute to the decrease in synaptic NMDAR currents
and the displacement of NR2B from synapses observed in GFPNR3A transgenic mice, and
would also explain why NMDARs concentrate earlier at NR3A knockout synapses.
Both the NMDAR and AMPAR component of synaptic currents were decreased in
GFPNR3A transgenics, and NMDAR/AMPAR ratios indicated that the magnitude of these
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reductions was roughly proportional. Whereas one might initially have predicted that
preventing developmental removal of NR3A might decrease this ratio—because NR1/NR2/
NR3A channels with lower conductance would not be efficiently replaced by NR1/NR2
heteromers—, the lack of changes likely reflects decreases in AMPAR currents that could be
the result of compensatory mechanisms, or of NR3-induced plasticity differences. For
instance, prolonged NR3A expression might cause an increase in the fraction of NMDAR-
only synapses; this is the expected outcome if maturation is partly achieved by adding
AMPARs to NMDAR-only synapses (Durand et al. 1996). If so, any gains in the NMDAR
component owing to an increase in NMDAR-only synapses could be offset by counteracting
decreases due to the reduced conductance of NMDARs containing NR3. This scenario
would be consistent with the trend towards a lower NMDA/AMPA ratio seen for
spontaneous miniature events, the lack of a corresponding difference in the evoked ratio
(Figure 6D), and the decrease in evoked AMPA responses, with no decrease in the
amplitude of spontaneous AMPAR minis (Figure 6C). Proportional scaling could
alternatively occur because AMPA and NMDA receptors tend to co-regulate in a
homeostatic process (Watt et al., 2000). Further studies will be needed to distinguish
between these two scenarios.
The transient nature of NR3A-induced changes in synapse density, but not in size, was
unexpected. However, transient alterations in synapse/spine density have also been observed
at similar stages of development in mouse models of fragile X and Rett syndromes
(Nimchinsky et al., 2001; Chao et al., 2007). One possibility is that other cofactors that are
permissive for spine pruning are also developmentally regulated. For example, sensory
deprivation in visual cortex increases pruning mainly during the physiological critical
period, reflecting a requirement for the proteolytic activity of tissue plasminogen activator
(Mataga et al., 2004). Additionally or alternatively, the transient alteration in spine density
could reflect a compensatory or homeostatic up-regulation of spine number triggered by
prolonged NR3A expression; prior studies have shown that possibly relevant homeostatic
mechanisms can be age-dependent and more pronounced in adult neurons (Kirov et al.,
2004).
Cognitive development and structural plasticity
Cognitive development requires the remodeling and stabilization of synaptic connections in
response to experience in order to support the acquisition and long-term storage of
information. Pharmacological or genetic models based upon complete inhibition of NMDAR
transmission disrupt both LTP and acquisition of spatial and associative memories (Morris,
1989; Rampon et al., 2000; Tsien et al., 1996). More selective manipulations such as genetic
deletion or C-terminal truncation of NR2A subunits, which interfere with synaptic NMDAR
stabilization as does prolonged GFPNR3A expression, reduce the magnitude of LTP to a
lesser extent and impair flexible memory processing with, at most, subtle effects on
acquisition (Sakimura et al., 1995; Steigerwald et al., 2000; Bannerman et al., 2008). This
phenotype resembles behavioral abnormalities in GFPNR3A transgenics, which show
normal to mildly impaired memory acquisition of spatial and associative tasks but are more
severely impaired in tasks involving working memory (reversal learning).
Fewer studies support an involvement of NMDARs in long-term memory storage and their
results have been controversial, in part because of difficulties in dissociating acquisition and
consolidation. For instance, inducible genetic ablation of NR1 in CA1 pyramidal cells 1–7
days after training interferes with consolidation of spatial memories in the Morris water
maze (Shimizu et al., 2000), but intra-ventricular AP5 infusion over the same time-scale
does not (Morris, 1989). It has also been unclear whether NMDARs are required for the
initial conversion of short- into long-term memories, a phase of memory consolidation
which is completed in the hippocampus within a few hours of training, or for later phases of
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consolidation in the neocortex (Cui et al., 2004). Here we demonstrate that prolonged
expression of NR3A-containing NMDARs dramatically impairs long-term memory in a
variety of behavioral tasks assessing spatial or associative memory, and using single or
repeated training events. Combined with the lack of short-term memory impairments, these
results reveal a striking ability of NR3A subunits to disrupt memory consolidation. Further,
the experiments using tasks which require brief training, such as object recognition or social
transmission of food preference, showed that impairments in memory consolidation were
already evident by 24 hours, suggesting that proper NMDAR transmission is required for the
stabilization of initially fragile memory traces within the hippocampus.
However, because GFPNR3A expression was not restricted to the hippocampus, we cannot
exclude contributions of inhibited synaptic stabilization in forebrain areas such as the
prefrontal and anterior cingulate cortices, which express low levels of the transgene and
participate in later phases of long-term memory storage (Frankland and Bontempi, 2005;
Wiltgen et al., 2004). Such a contribution is also suggested by the observation that memories
deteriorate over time, between 24 hours and 10 days, in GFPNR3A transgenics. In this
context, our findings of altered PSD length and spine size/shape in GFPNR3A transgenics
support a model whereby both early and late phases of memory consolidation are mediated
by structural changes at postsynaptic sites (Lamprecht and LeDoux, 2004), and are
consistent with studies linking long-term memory impairments with genetic manipulations
of other molecules involved in structural plasticity such as PAK, a regulator of actin
remodeling, or Arc/Arg 3.1 (Hayashi et al., 2004; Plath et al., 2006).
NR3A and diseases of development
Elevated NR3A levels have been reported in the brains of schizophrenic subjects, and our
animal model shows that impaired NR3A expression results in an imbalance between
synapse maturation and elimination, reproducing synaptic and cognitive problems typical of
schizophrenia, such as defects in working memory, behavioral flexibility, and memory
consolidation (Frantseva et al., 2007; Garey et al., 1998). In addition to schizophrenia, a
number of postnatal developmental disorders are associated with immature spine formation,
and we now provide evidence that an immature synaptic state can lead to profound cognitive
deficits. Thus, transgenic mice with persistent NR3A expression might provide a “synaptic”
model for schizophrenia and other cognitive disorders useful for exploring therapies based
on NR3A regulation to overcome NMDAR dysfunction at the synapse. A key question
surrounding therapeutic strategies to treat diseases of the synapse is whether abnormal
synaptic phenotypes arising in development can be reversed in adulthood. Our study, along
with other recent work (Guy et al., 2007; Ehninger et al., 2008), shows that restoring normal
protein expression at either juvenile or adult ages results in robust phenotypic reversal.
These findings demonstrate a remarkable capacity for adult plasticity at the level of the
synapse and raise hopes that late pharmacological or genetic interventions can normalize
behaviors in disorders of the synapse.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Expression of GFPNR3A in transgenic mice
(A) Constructs used for reversible production of GFPNR3A transgenic mice. The CaMKIIα
promoter determines the temporal/spatial expression pattern of tTA. In the absence of
doxycycline, the tTA protein drives expression of GFPNR3A linked to the tetO promoter
(Gene ON). (B) Direct GFP visualization of GFPNR3A protein in the forebrain of double
transgenic mice at postnatal day 25 (P25). Scale bar: 100 μm (25 μm in insets). Note high
levels of expression in the striatum, specific cortical layers, and hippocampal CA1. (C)
Dendritic targeting of GFPNR3A in pyramidal neurons of CA1 hippocampus (left, middle)
and layer IV of the neocortex (right), shown by DAB-enhanced immunohistochemistry
using anti-GFP antibody. Scale bars: 50 μm (left), 10 μm (middle, right). (D) Expression of
transgenic GFPNR3A is regulated by doxycycline administration as shown by DAB-
enhanced anti-GFP immunohistochemistry. Gene ON, P26 transgenic mice raised off
doxycycline; Gene OFF, P26 transgenic mice shifted onto doxycycline at P21 (2 mg/ml in
drinking water for 5 days) after allowing transgene expression at early stages.
Abbreviations: St, striatum; SS1, primary somatosensory cortex; CA1, CA1 hippocampus; s
rad, stratum radiatum; Cg, cingulate cortex; OT, olfactory tubercle; LS, lateral septum; Hi,
hippocampus; Amy, amygdala. Scale bar: 500 μm.
Roberts et al. Page 16













Figure 2. GFPNR3A-containing NMDARs are functional and inserted into synapses
(A) Transgenic GFPNR3A assembles with endogenous NMDAR subunits. Total membrane
extracts from hippocampi of P25 double transgenic mice were solubilized,
immunoprecipitated with anti-GFP antibody and immunoblotted with the indicated
antibodies. Additionally, 5% of the lysate (Input) used for immunoprecipitation was loaded.
(B–C) Effect of prolonged NR3A expression on synaptic NMDAR currents. Data are from
pharmacologically-isolated NMDAR-mediated EPSCs recorded from CA1 pyramidal
neurons and evoked by Schaffer collateral stimulation. (B) Input-output (I–O) curve
demonstrating that the amplitude of synaptic NMDAR currents recorded at +40 mV is
reduced in neurons from P21–P25 GFPNR3A transgenic mice (dt GFPNR3A). RMANOVA
revealed a significant main effect of genotype (F(1, 17) = 10.56, p < 0.01). In this and all
subsequent figures, error bars represent s.e.m. (C) Current-voltage (I–V) curve
demonstrating reduced rectification of synaptic NMDAR currents measured in the presence
of 4 mM Mg2+ in neurons from P21–P25 GFPNR3A transgenics. RMANOVA indicated a
significant main effect of genotype (F(1, 25) = 4.22, p < 0.05). (D) Synaptic NMDAR
currents recorded in CA1 neurons from NR3A knockout mice after Schaffer-collateral
stimulation exhibit stronger rectification at early postnatal stages (P6–P8) but normalize
afterwards. (E) Comparison of sensitivity to Mg2+ block indexes (1/C0) calculated for
NMDARs in control, GFPNR3A transgenic and NR3A knockout mice at the ages indicated.
Results are averages of 1/C0 values calculated from I/V curves fitted as described in
Appendix S1 (n= 6–14 mice per group).
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Figure 3. Hippocampal LTP is attenuated in GFPNR3A transgenic mice
(A) LTP evoked by HFS of Schaffer collaterals and measured with field excitatory
postsynaptic potentials (fEPSPs) in the CA1 region of the hippocampus is attenuated in P25
GFPNR3A transgenic mice (p < 0.005, Student’s t-test). Inset: Representative traces from
the average of 30 traces before and after HFS in slices from control and GFPNR3A
transgenic mice. (B) A stronger LTP protocol (3 epochs of HFS, arrows) was unable to
rescue the deficit in GFPNR3A transgenic mice (p < 0.05, Student’s t-test). Inset:
Representative traces from the average of 30 traces before and after repeated HFS in slices
from control and GFPNR3A transgenic mice. (C) No apparent defects in LTD induced by
low-frequency stimulation (LFS). Inset: Representative traces from the average of 30 traces
before and after LFS in slices from control and GFPNR3A transgenic mice. (D) PPF
(interstimulus interval: 25 ms to 250 ms) data indicate that release probability is similar in
neurons from P25 control and transgenic mice. Inset: Representative traces from control and
GFPNR3A transgenic experiments taken from the 25 ms interval. (E) Administration of
doxycycline for 14 days (from P26–P40, see scheme) normalizes LTP deficits in GFPNR3A
transgenics.
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Figure 4. Decreased spine density in CA1 hippocampal neurons of GFPNR3A transgenic mice
(A) CA1 pyramidal neurons in acute hippocampal slices were filled with Alexa 568 (50 μM)
via the patch pipette and transgenic neurons were identified by GFP-fluorescence. A
maximum projection image of a filled control CA1 neuron is shown. Scale bar, 100 μm. (B)
Only a fraction of CA1 pyramidal neurons express GFPNR3A. GFP-positive neurons
(green) were counted on confocal hippocampal sections from double transgenic mice
counterstained with TO-PRO-3 (blue) to label all nuclei. Scale bar, 50 μm. For quantitative
analysis, brains from 10 double transgenic P25 mice were used and confocal CA1 images
were acquired at various distances from the central line for neuronal counting (see schematic
inset). Higher numbers of GFP-positive cells were found close to the subiculum. (C)
Representative high magnification projections of Alexa 568-filled apical dendritic segments
of P25 control and GFPNR3A-expressing CA1 neurons. Scale bar, 3 μm. (D) Mean spine
densities in apical dendrites of P25 control and GFPNR3A-expressing CA1 neurons. Values
from 3–10 secondary/tertiary dendrites were averaged to yield individual neuron parameters
(* p < 0.05, ANOVA followed by Tukey’s t-test, n = 6–11 neurons per group). (E) Spines
were grouped in different morphological categories and spine densities for the different
categories were calculated as in D (see examples in C). (F) Representative apical dendritic
segments of Golgi-impregnated CA1 pyramidal neurons from P25 control and GFPNR3A
transgenic mice. Scale bar, 5 μm. (G) Mean spine densities in apical dendrites from CA1
pyramidal neurons. Values from 3–5 secondary/tertiary dendrites were averaged to calculate
individual neuron parameters (* p < 0.005, ANOVA followed by Tukey’s t-test, n = 34–45
Golgi-stained neurons from 7–8 control and GFPNR3A transgenic mice).
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Figure 5. GFPNR3A transgenic mice have fewer and smaller synapses
(A, B) Electron microscopy analysis shows reduced synapse density in the stratum radiatum
of hippocampal CA1 from P25 GFPNR3A transgenic mice. s, spine. (C) Left, mean PSD
length was significantly reduced in P25 GFPNR3A transgenics. Right, cumulative
distribution plots reveal a shift towards synapses with shorter PSDs in P25 transgenic mice.
(D, E) Synapse numbers (D) but not PSD length (E) returned to control levels by P35.
Doxycycline administration for 10 days (from P26–35, see scheme) reversed the changes in
PSD length. No differences in synapse number or size were observed between doxycycline-
treated and untreated control mice (* p < 0.001, ANOVA followed by Tukey’s test, n = 6–8
mice per group, 10 fields of each animal were randomly acquired at the level of the central
stratum radiatum and analyzed in a blind fashion).
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Figure 6. Altered NR3A expression decreases functional synapse number
(A–C) mEPSCs from P25 GFPNR3A transgenic mice have decreased frequency but
unchanged amplitude. (A) Representative traces of mEPSC recordings made at −80 mV in
the presence of 0.2 mM TTX and 0.05 mM picrotoxin in neurons from control and
GFPNR3A transgenic mice. The middle panel is the average of all mEPSCs from a
representative experiment in control and transgenic mice. (B) Averaged data and cumulative
probability histograms of mEPSC frequencies demonstrating a lower probability of
spontaneous events in neurons from GFPNR3A transgenic mice (* p < 0.02, Student’s t-
test). Grey trace indicates control data, black trace represents data from GFPNR3A
transgenic experiments. (C) Averaged data and cumulative probability histograms of
mEPSC amplitudes. (D) Ratio of NMDAR to AMPAR current does not differ between P25
control and GFPNR3A transgenics. Ratios were calculated from spontaneous synaptic
events recorded at +40 mV before and after application of APV to estimate each component
(D1), or from synaptically evoked currents measuring the AMPAR component at −80 mV
and the NMDAR component at +40 mV at a time (indicated by dotted line) when the
AMPAR component had largely decayed (D2).
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Figure 7. Genetic deletion of NR3A accelerates the developmental onset of LTP and synaptic
maturation
(A) LTP evoked by HFS and measured in the CA1 region of the hippocampus is enhanced
in P6-8 NR3A knockout mice when compared to control wild-type mice (p < 0.05, Student’s
t-test), while the magnitude of LTP at P14–P18 and in adults is similar between genotypes.
(B) Immunoblot analyses of NMDAR subunit abundance show that NR1 levels are
significantly increased in forebrain synaptic fractions from P6-8 NR3A knockout mice (* p
< 0.01 vs wild-type, Student’s t-test, values within bars represent sample sizes). Protein
expression data are averages of densitometric values (OD) relative to protein loads.
Representative immunoblots are shown. PNS, postnuclear supernatant, SPM, synaptic
plasma membrane, PSDI, postsynaptic fraction. (C) Input-output (I–O) curve demonstrating
that the amplitude of synaptic NMDAR currents recorded at +40 mV is enhanced in neurons
from P6-8 NR3A knockout mice. RMANOVA revealed a significant main effect of
genotype (F(1, 15) = 6.65, p < 0.05).
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Figure 8. Disrupted long-term storage of spatial memory in GFPNR3A transgenic mice
(A) Diagram showing training protocols used for assessment of spatial memory in the
Morris water maze; remote memory tests are indicated by vertical arrows. (B, C) Adult
GFPNR3A transgenic mice display normal acquisition of spatial reference memory, as
shown by declines in swim distances and times to locate the hidden platform, but their
performance is poorer than controls after platform reversal. Remote memory testing was
conducted 21 days after the initial 6 day training period (day 27), and then mice were
retrained for 3 days to restore performance. Transgenic mice showed longer swim distances
during retraining, but by day 30 both control and transgenic mice returned to day 6 levels.
After changing the platform location from the NE to the SW quadrant, swim distances and
times were longer for both genotypes on day 31 and 32 relative to day 6 or 30. By day 33,
controls returned to levels observed on day 30, but GFPNR3A transgenics needed more days
of training to achieve these levels. (D) Control and transgenic mice showed no differences in
learning to swim to a visible platform. (E) Probe trials for acquisition given at the end of test
days 3, 6, and 27. Dashed lines indicate chance levels (25%). Note that both control and
transgenic mice learned the hidden platform location, but remote memory was significantly
impaired in GFPNR3A transgenics. (F) Probe trials for reversal testing given at the end of
test days 33 and 36; remote memory was assessed 21 days later (day 57). Both control and
transgenic mice learned the new platform location, as shown by a preference for the SW
compared to NE quadrants on day 36 (* p < 0.05 control vs transgenics, Bonferroni
corrected pairwise comparisons, n = 10 mice/genotype).
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Figure 9. Deficits in long-term memory are reversible
(A, B) Adult GFPNR3A transgenic mice exhibit anomalies in long-term memory in social
transmission of food preference and object recognition tests. (A) Transgenic mice
demonstrate reduced preferences for the familiar diet at 20 min and 24 hrs, and no
preference for either the familiar or novel diet at 10 days relative to controls. Bonferroni
post-hoc comparisons found significant differences between control and transgenic mice at
20 min (p < 0.036), 24 hrs (p < 0.006), and 10 days (p < 0.001). Control preference scores
did not differ between test times, but transgenics showed a reduction in preference at 10
days compared to 20 min (p < 0.002) and 24 hrs (p < 0.001). (B) Transgenic mice display
intact object recognition at 20 min but are impaired at 24 hrs and 10 days. Control
preference scores did not differ between test times, whereas mutants showed a graded loss in
preference over time. Hence, preferences for control and transgenic mice were similar at 20
min, but differed at 24 hrs (p < 0.016) and 10 days (p < 0.001). (C) Defects in long-term
memory are reversible. Transgenic mice were raised off-doxycycline to allow GFPNR3A
expression, and treated with doxycycline for 14 days before testing. Treatment was
continued during the consolidation phase (see scheme, vertical arrows indicate test times).
Note that adult transgenic mice display normal object recognition memory at all times
following doxycycline treatment. Moreover, when compared to untreated transgenic mice,
doxycycline-treated transgenics showed the same performance at 20 min, but enhanced
memory for the novel object at 24 hrs and 10 days (n = 9–10 mice/genotype/treatment; *p <
0.05 from controls, +p < 0.05 from 20-min test, ^p < 0.05 from 24-hr test, #p < 0.05 from
water-treated transgenics).
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